William Blair analyst Brian Weinstein reiterated an Outperfom rating on Sequenom (NASDAQ:SQNM), following the news that Sequenom and Illumina reached an agreement to settle all pending IP claims …
Oppenheimer analyst Bret Jones reiterated an Outperform rating on Sequenom (NASDAQ:SQNM) with a $5.00 price target, as Sequenom and Illumina reached an agreement to settle all …
Oppenheimer analyst Bret Jones maintained an Outperform rating on Sequenom (NASDAQ:SQNM) with a price target of $5.00, which represents a potential upside of …
In what I hope will become the first in a series of Infrequently Asked Questions, I was able to chat with Sequenom (NASDAQ:SQNM) …
On Tuesday, July 29 Sequenom (SQNM) reported second quarter 2014 results that included revenue of $39.8 million, which was a bit shy of the consensus …
